Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Ilika, Faron Pharmaceuticals, Hercules, Genflow Biosciences, Frontier IP Group, Bluefield Solar Income Fund - Small Cap Week in Review

Ilika, Faron Pharmaceuticals, Hercules, Genflow Biosciences, Frontier IP Group, Bluefield Solar Income Fund - Small Cap Week in Review

Ilika PLC (AIM:IKA, OTCQX:ILIKF) has completed commissioning of its Goliath pilot line for solid-state batteries. It’s now producing larger prototype batches, moving closer to customer testing and potential licensing deals. Watch more

Faron Pharmaceuticals Limited (AIM:FARN) shared what it called “game-changing” clinical data for its drug bexmarilimab in high-risk MDS. The treatment showed an 85% response rate, and Faron’s now preparing for a registration trial. Watch more

Hercules PLC (LSE:HERC) has bought Lyons Power Services, adding to its growing energy infrastructure portfolio. The deal builds on its Advantage NRG acquisition and strengthens its role in the UK’s clean energy transition. Watch more

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has secured a second European patent for its Sirtuin-6 technology. The new protection boosts its position in longevity and metabolic disease and supports future pharma partnerships. Watch more

Amprologix, a Frontier IP Group, PLC (LSE:FIPP) portfolio company, has raised £740,000 to advance its MRSA-fighting antibiotic, Epidermicin NI01. The funding will complete preclinical studies ahead of human trials, targeting a major global health challenge. Watch more

Bluefield Solar Income Fund (LSE:BSIF) has reported strong results and proposed internalising management to tackle its share price discount. The plan could unlock long-term value as it shifts toward becoming an independent power producer. Watch more

Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK